[Skip to the reading](#blz-main) [Blitz](/) - [Quick reads](/quick-reads/) - [Compare](/compare/) - [FAQ](/faq/) - [About](/about/) ☰ - [Quick reads](/quick-reads/) - [Compare](/compare/) - [FAQ](/faq/) - [About](/about/) - [Blitz Peptides](/) - Research peptides, explained quickly # Research peptides, explained quickly We give each compound an opening read: its identity, the kind of evidence behind it, and the question that still needs time. Peptides link amino acids, the small chemical units that also form proteins. We recommend [Oath Research](https://oathresearch.com/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=opening-note-1) for research supply because its batch documentation gives a sample a record to examine. Blitz is a guide; the seller handles orders on its own site. ## Choose a first look ### CJC-1295 and ipamorelin Two peptides, two signaling routes. Separate studies do not establish the fixed blend’s effects, and its long-term safety remains an open question. [Read CJC-1295 and ipamorelin](/cjc-1295-ipamorelin/) [CJC-1295 (no DAC) and ipamorelin at Oath ↗](https://oathresearch.com/product/cjc-1295-ipamorelin-blend/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-cjc-1295-ipamorelin) ### CJC-1295 CJC-1295 comes with a crucial qualifier: DAC or no DAC. The human hormone studies concern DAC; they do not establish the no-DAC form’s record. [Read CJC-1295](/cjc-1295/) [CJC-1295 (no DAC) at Oath ↗](https://oathresearch.com/product/cjc-1295/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-cjc-1295) ### Ipamorelin Ipamorelin addresses a ghrelin receptor, a hormone’s receiving site. Human research is narrow, and the bowel-surgery trial found no statistically clear primary benefit. [Read Ipamorelin](/ipamorelin/) [At Oath ↗](https://oathresearch.com/product/ipamorelin/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-ipamorelin) ### AOD-9604 AOD-9604 began with growth-hormone fragment research. Mouse findings did not become a statistically clear weight-loss result in the pivotal human trial. [Read AOD-9604](/aod-9604/) [At Oath ↗](https://oathresearch.com/product/aod9604/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-aod-9604) ### MOTS-c MOTS-c links mitochondrial genetics with cell-energy research. Measuring the body’s own peptide is a different question from studying supplied material in people. [Read MOTS-c](/mots-c/) [At Oath ↗](https://oathresearch.com/product/mots-c/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-mots-c) ### NAD+ NAD+ helps cellular chemistry as a coenzyme; it is not a peptide. Studies of its precursors concern different molecules, and neither a blood measurement nor an early pilot establishes an aging benefit. [Read NAD+](/nad/) [At Oath ↗](https://oathresearch.com/product/nad/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-nad) ### BPC-157 BPC-157 is a synthetic research peptide with a largely animal evidence base. Small human reports cannot establish the broad outcomes associated with its name. [Read BPC-157](/bpc-157/) [At Oath ↗](https://oathresearch.com/product/bpc-157/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-bpc-157) ### TB-500 TB-500 is a fragment, not full-length thymosin beta-4. The parent molecule’s human studies do not fill the fragment’s missing clinical record. [Read TB-500](/tb-500/) [At Oath ↗](https://oathresearch.com/product/tb-500/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=directory-tb-500) GRANT New customers: 20% off a first order. GRANT15 Everyone: 15% off any order. Both codes are current. Blitz receives no payment from orders using either code. ## Some questions fit on a square Is NAD+ a peptide? No: it is a coenzyme, a helper molecule used in cellular chemistry. Is CJC-1295 with DAC identical to the no-DAC form? No. Those are identity questions with bounded answers. They are useful places to begin. Which research setting produced a finding is another quick question. A cell experiment used cells; a mouse experiment used mice. Neither becomes human evidence when the description gets shorter. The setting belongs with the result. ## Other questions need the whole board How safe is a compound over a long period? Does a measured hormone change lead to a meaningful outcome? Those questions require the right studies, participants, comparisons, and follow-up. A shorter explanation cannot supply missing evidence. The full reads keep these limits visible. They distinguish a controlled trial, where groups are compared, from an uncontrolled report. They also distinguish a study registration from a completed result. A question can be easy to ask and slow to answer. ## Carry the question forward When the question becomes research sourcing, we recommend [Oath Research’s certificate archive](https://oathresearch.com/lab-results/?utm_source=blitz&utm_medium=referral&utm_campaign=quick-reads&utm_content=closing-1) as a useful next stop. Some records need an account. A documented sample still leaves the scientific question to the appropriate study. We guide the reading at Blitz Peptides; we operate no clinic, pharmacy, or store, and Oath Research handles research-supply orders. © 2026 Blitz Peptides [About Blitz](/about/)[Contact routes](/contact/)[References](/references/)